Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic

1Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA 2Division of Hematology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 3Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA 4Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, North Carolina, USA 5Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA